Tesamorelin

Tesamorelin is a 44-amino-acid synthetic peptide classified as a growth hormone-releasing hormone (GHRH) analogue. Structurally, it corresponds to the biologically active 1-44 fragment of human GHRH, with a trans-3-hexenoic acid group conjugated to the N-terminus. This modification is the defining feature that separates tesamorelin from native GHRH in laboratory characterization work, and it is the reason researchers select tesamorelin specifically when a longer plasma observation window is needed for pituitary-axis experiments.

As a GHRH analogue, tesamorelin is studied for its interaction with the GHRH receptor (GHRH-R) expressed on anterior pituitary somatotroph cells. Receptor binding activates a Gs-protein-coupled cascade that raises intracellular cAMP, a signaling step researchers track when characterizing growth hormone (GH) synthesis and pulsatile release in vitro and in animal models. Because tesamorelin retains full agonist activity at GHRH-R while resisting the enzymatic cleavage that limits native GHRH, it has become a standard reference compound in GHRH analogue research on receptor selectivity, signal transduction, and comparative pharmacokinetics.

The trans-3-hexenoic acid modification protects tesamorelin from dipeptidyl peptidase IV (DPP-IV), the enzyme primarily responsible for the rapid plasma clearance of unmodified GHRH. Plasma incubation studies paired with LC-MS/MS quantification are the standard methodology researchers use to characterize this resistance, comparing degradation curves of tesamorelin against native GHRH and against other GHRH-axis analogues such as sermorelin and CJC-1295. This comparative stability profile is a recurring reference point in peptide-axis literature and a key reason tesamorelin research peptide protocols favor it for extended time-course sampling.

Beyond receptor pharmacology, tesamorelin research peptide protocols extend into GH/IGF-1 axis regulation, visceral adipose tissue biology, hepatic lipid metabolism, and, in more exploratory work, hippocampal and cognitive-marker studies. Rodent and in vitro models are used to examine how sustained GHRH receptor stimulation feeds forward into IGF-1 production, adipocyte gene expression, and lipoprotein profiles.

Tesamorelin reconstitution in a laboratory setting follows standard peptide-handling protocol: the lyophilized powder is brought to room temperature, then a sterile diluent such as bacteriostatic water is added slowly down the vial wall and mixed by gentle swirling rather than shaking, which can disrupt the peptide's secondary structure. Reconstituted stock solutions are typically prepared to a defined mg/mL concentration for aliquoting into assay volumes, kept refrigerated at 4 degrees C, and used within 24 hours since the product contains no preservative. Unreconstituted, lyophilized tesamorelin should be stored at -20 degrees C, sealed and protected from light, to preserve peptide integrity for longer-term laboratory inventory.

Researchers who buy tesamorelin research peptide from Optimum ReGen Peptides receive product compounded by a licensed US 503A pharmacy, with each production batch verified at 99% or greater purity by third-party HPLC testing and a corresponding certificate of analysis available per lot. Tesamorelin for sale on this page is listed in multiple lyophilized quantities to support laboratories scaling from single-vial pilot work up to larger multi-kit study designs, with COAs, purity data, and cold-chain shipping handled from dispatch to delivery. Every tesamorelin peptide buy order placed through this site is limited to qualified research use and processed accordingly.

This tesamorelin listing is intended strictly for laboratory and in vitro research by qualified professionals and institutions. It is not for human consumption, not for veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease. No content on this page constitutes medical advice or guidance for human administration; all handling described here refers to laboratory research protocol only.

Tesamorelin is in stock and available to buy online from Optimum ReGen Peptides — a real American research-peptide company with a physical storefront in Medford, Oregon, not an anonymous overseas dropshipper. Priced from $50, every order ships within two business days, flat $13 nationwide, in plain discreet packaging with tracking.

As your Tesamorelin supplier we back every batch with a third-party certificate of analysis and compound in a licensed US 503A pharmacy. Vials are supplied lyophilized at analytical purity for laboratory and research use only, not for human consumption.

In preclinical studies, Tesamorelin is administered by subcutaneous injection to rodent models, with blood sampling at defined intervals to construct GH pulse profiles using ultrasensitive immunoassays. IGF-1 and IGFBP-3 serum levels are quantified by ELISA as downstream markers of somatotroph axis stimulation. Adipose tissue is harvested for gene expression profiling using RT-PCR panels targeting lipogenic and lipolytic enzyme genes.

Researchers characterize Tesamorelin's DPP-IV resistance by incubating the compound in plasma preparations and comparing intact peptide recovery over time against unmodified GHRH using LC-MS/MS. This confirms that the N-terminal modification confers the intended enzymatic stability and validates the pharmacokinetic rationale for the structural design.

In metabolic research designs, indirect calorimetry, body composition analysis by DEXA or MRI, and comprehensive metabolic panel measurement are used as systemic endpoint readouts in animal model studies. Researchers also examine pituitary somatotroph density and GH granule content by electron microscopy in long-term treatment cohorts to assess gland-level response to chronic GHRH receptor stimulation.